SOMATEX Medical Technologies GmbH
Somatex_Medical-Technologies-GmbH   Somatex_Medical-Technologies-GmbH
Deutsch English  Pусский 
Newsletter Contact Press
Development without compromises
Biopsy Drainage Hematology - Oncology LITT Mammography MRI Devices Antenatal Diagnostics Special Products Vertebroplasty
Press
PRESS RELEASES
Optimal visibility, low level of artefact formation, and high stability in MRI

World premiere of Somatex’ new magnetic resonance imaging product range at the 89th German Roentgen Congress in Berlin

Teltow, 28.04.2008. Somatex Medical Technologies is to premiere at the 89th
German Roentgen Congress in Berlin a new product range of instruments for
minimally invasive surgical procedures using a magnetic resonance image scanner.
Through the use of a new alloy, these instruments can achieve excellent visibility with minimal artefact formation and high levels of material strength.


New eye protectors and a new generation of minimally invasive instruments
SOMATEX presents its product spectrum at Medica and ComPaMED

Teltow, 12th November, 2007. At the Medica trade fair in Düsseldorf from 14th to 17th November,
SOMATEX Medical Technologies will present, amongst other innovations, its newly developed radiation protector, designed for use during CT scans of the head. The new protector represents an important contribution to a more active patient protection, as it greatly reduces the exposure of radiation to sensitive eyes, thus significantly lessening the risk of eye cataracts developing as a result of repeated CT scans.

One and a half decades of innovation
SOMATEX, manufacturer of technical equipment for the medical industry, has been successfully established on the market for some 15 years, and is now forging further ahead – introducing new products and drawing up an audit of its "soft" success factors.

Teltow, October 9th, 2007. Since 1992 Somatex Medical Technologies GmbH has been developing and manufacturing minimally invasive instruments for clinical use. Innovative technical processes, consistently high product quality, and an unwavering focus on the ergonomy of the instruments, have led to SOMATEX’ success in establishing its developments not just on the German market, but also further afield.

Again a Higher Turnover with Minimum Invasive Instruments
SOMATEX Medical Technologies increases its annual turnover and expands its international activities

In the past year, the medical technology manufacturer SOMATEX Medical Technologies was able to increase its net income before taxes by 66.99%. In particular, the minimum invasive instruments used for tumor marking and diagnosis in magnet resonance imaging (MRI) much contributed to the good results: turnover in this area has increased by 60%. The sale of instruments used in mammography and oncology also increased by 20% each.

Official Start of Leakless Vertebral Reposition Therapy (LVRT) Project
International Consortium Headed by SOMATEX® Develops New Osteoporosis Pain Therapy

Teltow, December 11, 2006. The development of the "Leakless Vertebral Reposition Therapy" (LVRT) is a significant step to stop pain due to vertebral fractures. The LVRT project initiated by Fraunhofer Gesellschaft and SOMATEX is subsidized by the European Union in the context of its CRAFT programme.

Innovation Award for Cement Injection System CIS from Somatex
Somatex Medical Technology for Stabilizing Injured Vertebrae Awarded Again
Teltow, May 30, 2006. More than 200 companies presented their most innovative products to a jury in order to win the Innovation Award 2006 for the German Industry offered by the "Initiative Mittelstand". Meanwhile, the decisions have been made: The Teltow-based company Somatex Medical Technologies GmbH has won the second place in the "Medical Technology" category for its Cement Injection System CIS.

Somatex Medical Technology for Stabilizing Injured Vertebrae Awarded Again
Medical Technology: Strong Demand for Quality made in Germany

Somatex Medical Technologies was able to strongly increase its annual turnover by selling minimum invasive single-use instruments

Teltow March 06, 2006. As in the past, there is strong demand for quality products made in Germany, in particular in sensitive areas such as health and healthcare. This is why the medical supplier Somatex Medical Technologies was able to increase its profit by 17% and its turnover by a total of 11% last year by selling minimum invasive single-use instruments. Especially the sale of mammography instruments and products for vertebroplasty - i.e. the treatment of injured vertebral bodies - accounted for a plus of 34% resp. 37% and thus contributed considerably to this growth.

Somatex Minimum Invasive Medical Devices Now Available in Russia As Well

Somatex products successful at medical fair "Zdravookhranenie" in Moscow

Teltow, December 12, 2005. The products of Somatex Medical Technologies have received final approval and are now available on the Russian market. The minimum invasive single-use instruments were certified according to the Russian GOST standard and can from now on be sold to Russian customers. Somatex offers systems for tumor marking, systems for tumor treatment by laser-induced interstitial thermotherapy (LITT), biopsy systems, drainage catheters to drain intra-abdominal liquid collections and the complete range of vertebroplasty products.

Somatex Presents New Biopsy and Tumour Marking Products

New disposable minimum invasion instruments QUICK-SHOT® and TULOC® presented at Medica fair

Teltow, November 11, 2005. Somatex extends its product range by two new disposable instruments to be used for biopsy and tumour marking: The semi-automatic QUICK-SHOT system was specifically developed for obtaining histologically usable tissue material from soft parts and organs. The TULOC product is a new set designed for precise tumour localization.
Products and Know-how of SOMATEX® now Available for Other Medical Device Suppliers

OEM Division set up to promote cooperation with other suppliers

Teltow, September 16, 2005. SOMATEX® Medical Technologies reacts to the increasing demand of other medical device suppliers and now offers its disposable minimum invasive instruments as an original equipment manufacturer (OEM). A new OEM Division was set up in order to make cooperations easier and to push ahead with them.

SOMATEX® Certified According to EN ISO 13485

SOMATEX® Medical Technologies fulfills the requirements of the standard EN ISO 13485:2003 one year before it is obliged to do so.

Teltow August 31, 2005. As a development-orientated medical technology company, SOMATEX® Medical Technologies has now been certified according to EN ISO 13485:2003. For this process of certification, the entire company was assessed. Certification was completed one year before it becomes mandatory on July 31, 2006. The following processes were examined: strategic processes (e.g. business targets), core processes (e.g. development and manufacturing), supporting processes (e.g. corporate communication) and quality management/documentation.

SOMATEX® sets new turnover record in first half-year of 2005

SOMATEX® Medical Technologies has increased its overall turnover by 15.5% compared to the first half-year in 2004.

Teltow, July 28, 2005. In its first half-year of 2005, the medical technology company SOMATEX® achieved a record result. SOMATEX® increased its overall turnover in sales of disposable minimum invasive instruments by 15.5 percent compared to the same period in 2004.

SOMATEX® Improves approved BRONCHO-CUT System

Three times as much biopsy material in aspiration cytology if using rigid fine needles

Teltow July 04, 2005. In diagnosing suspected lesions of the bronchial tract the bronchoscopically guided fine needle puncture has proven to be a particularly gentle method for patients. With the new improved BRONCHO-CUT ® 1.0 system, SOMATEX® now meets the requirements and requests of treating physicians who wish to have a considerably increased quantity of biopsy material for aspiration cytology purposes.

BRONCHO-CUT

Special Products -> BRONCHO-CUT® Expert 

SOMATEX® Medical Technologies among the TOP 100 Enterprises

Medical technology company located in Teltow wins prize for being one of the most innovative medium-sized companies in Germany

Teltow, June 27, 2005. The company SOMATEX® Medical Technologies achieved the quality seal ”TOP 100” for its excellent innovative accomplishments. The award was given to the company by TOP 100 patron Lothar Späth on June 22, 2005, at the awards ceremony at the Grand Hyatt Hotel in Berlin.

Somatex, ausgezeichneter Innovator im deutschen Mittelstand
Less Effort Needed to Get a Better Quality of Biopsy Material

Study confirms: ”Safe-Cut®” from SOMATEX® considerably improves handling in bone marrow punctures and quality of the biopsy material obtained.

Teltow, May 26, 2005. Bone marrow punctures are indispensable for diagnosing numerous hematological and oncological diseases. Due to the patient’s enormous stress and the risk of infection it is very important that the first attempt of puncture already yields enough bone marrow material in sufficient quality.

Hematology - Oncology -> SAFE-CUT® 

Medical Technology from SOMATEX® now in Italy and France

SOMATEX® Medical Technologies signs cooperation agreement with Bloodline S.p.A. involving a total volume of EUR 1.2 m.

Teltow, May 17, 2005. SOMATEX® Medical Technologies consolidates its market leadership in the field of hematological-oncologic canula systems. The cooperation agreement with Italian company Bloodline S.p.A., a specialist in dialysis equipment and biopsy needles, allows a considerable expansion of the distribution network for SOMATEX® products.

Precise and Gentle Tumor Marking

SOMATEX® presents new Tumark® system at German Radiology Congress

Teltow, April 29, 2005. To efficiently treat tumors using chemo or radiation therapy, it is very useful to be able to precisely mark the affected tissue. At the German Radiol-ogy Congress taking place in Berlin from May 4 – 7, SOMATEX® Medical Technologies will present a new minimally invasive system to mark soft tissue, in particular breast tissue.

Increase in Turnover – Beneficial to All

Bonus scheme allows SOMATEX® employees to have a share in the company’s profits

Teltow 06.04.2005. In the first quarter 2005, SOMATEX® Medical Technologies increased its turnover by 11 percent compared to the according quarter in 2004. The company, specializing in medical technology, thereby continues its positive trend of the year 2004. The noticeable increase in turnover over last year’s level was not only achieved on the home market, but also in the export sector.

Biopsy Drainage Hematology LITT Mammography MRI Antenatal Diagn. Special Vertebroplasty
    

Information provided in this site is not intended to be used by physicians, other health care providers or patients in the United States of America. SOMATEX Medical Technolgies GmbH disclaims any liability for the acts in the United States of America of any physicians or any other individual or group acting independently or on behalf of any organization who receive any information on any medical product or procedure through this web site. SOMATEX Medical Technologies GmbH accepts no legal responsibility for any injury and/or damage to persons or property occurring in the United States of America as a result of any of the methods, products, instructions, suggestions, or ideas contained or discussed herein.